DEBBIE BURKHARDT: Open Payments
NPI 1154567105 · HUMBLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,885 in 94 payments from 23 companies in 2025. Trend: 2023 $2,411 · 2024 $2,267 · 2025 $1,885
Food & beverage: $1,885
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $268 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $261 |
| ABBVIE INC. | 13 | $190 |
| Corcept Therapeutics | 10 | $188 |
| AstraZeneca Pharmaceuticals LP | 4 | $144 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $137 |
| GlaxoSmithKline, LLC. | 4 | $94 |
| Lilly USA, LLC | 5 | $90 |
| Axsome Therapeutics, Inc. | 2 | $58 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $53 |
Products named: Kerendia, Korlym, JARDIANCE, AIRSUPRA, TRELEGY ELLIPTA, QULIPTA, Wegovy, UBRELVY.
Industry payments across TX — which companies pay providers there.
